Page last updated: 2024-10-27

fluconazole and Shock

fluconazole has been researched along with Shock in 1 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, YR1
Lin, LC1
Young, TG1
Liu, CE1
Chen, CH1
Tsay, RW1

Other Studies

1 other study available for fluconazole and Shock

ArticleYear
Risk factors for candidemia-related mortality at a medical center in central Taiwan.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2006, Volume: 39, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; APACHE; Candida; Candidiasis;

2006